ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Hikma Pharmaceuticals clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 118 studies whose lead sponsor is Hikma Pharmaceuticals or one of 2 companies grouped under it. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Our grouping of 4 registry names, not the registry’s. See them and correct one ↓

Pipeline: 1 program

Each counted once: 1 with a study Hikma Pharmaceuticals leads registered in the last two years.

  • Phase 2

The 1 program — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Hikma Pharmaceuticals’ own registered studies; Hikma Pharmaceuticals’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Hikma Pharmaceuticals’ studies test, most open studies first — 50 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 50; every drug is on its own page, and each page lists its sponsors.

Coming up

1 of Hikma Pharmaceuticals’ studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. 1M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 118 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now33%Recruiting 2 · Not yet recruiting 1
  • Under way, not recruiting11%
  • Completed11295%
  • Stopped early22%

Phase

  • Phase 111
  • Early Phase 16
  • Phase 43
  • Phase 33
  • Phase 22

Where

  • United States98
  • Jordan7
  • Egypt5
  • Canada4
  • Saudi Arabia4
  • Lebanon2

Over the years

  1. 1707
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 126

By the year each study started; 62 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Hikma Pharmaceuticals.

  • Roxane Laboratories
    Acquired — became part of Hikma Pharmaceuticals, Feb 29, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    99 studies →
  • Hikma Pharmaceuticals LLC
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    14 studies
  • West-Ward Pharmaceutical
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Hikma Pharmaceuticals USA Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study

Focus areas

Conditions Hikma Pharmaceuticals leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 118. Browse all 118 →